tirzepatide shortage resolved The FDA says the Zepbound is over. That's rattling the weight loss industry Update I received today. :

Considerations for specific populations: Individuals with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasias should avoid these medications Pregnant or nursing women are advised not to use semaglutide or Zepbound Those with a history of pancreatitis, certain thyroid cancers, or a slow digestive system should exercise caution While Zepbound may potentially present more frequent or severe side effects due to its higher potency, the overall risk profile is similar to that of semaglutide

this can be regarded as a strong indicator of PCOS diagnosis (254)

Disclaimer Healthline has made every effort to make certain that all information is factually correct, comprehensive, and up to date

Safety Considerations and Who Should Pursue Telehealth GLP-1 GLP-1 medications are contraindicated in pregnancy, personal or family history of medullary thyroid carcinoma, and severe kidney disease